These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33782980)

  • 1. Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance.
    Zhao S; Wang Y; Wu W; Yang S; Feng L; Tao F; Ge W; Shen M; Xu W
    Andrologia; 2021 Jul; 53(6):e14060. PubMed ID: 33782980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Link Between Non-Alcoholic Fatty Liver Disease and Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms: A Systematic Review and a Meta-Analysis.
    Besiroglu H; Kadihasanoglu M
    Metab Syndr Relat Disord; 2023 Sep; 21(7):370-377. PubMed ID: 37341680
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.
    Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Chisari M; Castelli T; Favilla V; Morgia G
    World J Urol; 2015 May; 33(5):743-51. PubMed ID: 25189458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores.
    Eren H; Horsanali MO
    BJU Int; 2019 Aug; 124(2):329-335. PubMed ID: 30900792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study".
    Uzun H
    World J Urol; 2015 May; 33(5):753. PubMed ID: 25578638
    [No Abstract]   [Full Text] [Related]  

  • 7. Benign prostatic hyperplasia and intraprostatic inflammation are associated with liver inflammation: it's time for prevention.
    Privitera S; Russo GI; La Vignera S; Condorelli RA; Calogero AE; Cantiello F; Damiano R; Favilla V; Cimino S; Morgia G
    Andrology; 2018 Sep; 6(5):737-741. PubMed ID: 29858538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia.
    Chung GE; Yim JY; Kim D; Kwak MS; Yang JI; Park B; An SJ; Kim JS
    J Korean Med Sci; 2020 Jun; 35(22):e164. PubMed ID: 32508064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
    Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
    Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review.
    Tsunemori H; Sugimoto M
    Int J Urol; 2021 Nov; 28(11):1086-1092. PubMed ID: 34342061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.
    Egan KB
    Urol Clin North Am; 2016 Aug; 43(3):289-97. PubMed ID: 27476122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
    Chiang BJ; Kuo HC; Liao CH
    Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    De Nunzio C; Salonia A; Gacci M; Ficarra V
    World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
    Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
    Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and its Potential Impact on Medical Therapy.
    Kaplan SA
    J Urol; 2016 Mar; 195(3):689-90. PubMed ID: 26887734
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.
    Mjaess G; Karam A; Roumeguère T; Diamand R; Aoun F; McVary K; Moul JW; De Nunzio C; Albisinni S
    Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):451-460. PubMed ID: 36209236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
    Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
    Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
    Nickel JC
    Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.